Angelini – CDMO – CRDMO: Tools and different business model for new opportunity in synthesis

287

INTRODUCTION
The active pharmaceutical ingredient (API) is the foundation of a final drug product and is a crucial consideration when choosing a Contract Development and Manufacturing Organisation (CDMO) or Contract Research (in House) Development and Manufacturing Organisation (CRDMO).